Tag: expert ideas

On The Key To Success

Charlie Munger’s Three-Step Wealth Accumulation Strategy: ‘Save Diligently, Seize Opportunities, And Continuously Self-Educate’

Admin Enterteno

In a 1998 Berkshire Hathaway shareholder meeting, renowned investor, Charlie Munger, unveiled his three-step strategy for wealth accumulation starting from scratch.What Happened: Munger discussed the challenge of building wealth from ground zero. He underscored that rationality, opportunism, and substantial saving are key to wealth creation.During the meeting, Munger advised saving a substantial part of one’s […]

Read More
Primo Brands Water Truck

Primo Brands Coverage Initiated: Analyst Sees EBITDA Gains From Cost Cuts, Bottled Water Momentum

Admin Enterteno

BofA Securities analyst Peter T. Galbo initiated coverage on Primo Brands Corporation (NYSE:PRMB), with a price forecast of $42.Galbo notes that Primo Brands stock is expected to appreciate over the next 12 months as the company realizes cost synergies, targeting $300 million in EBITDA by 2026.If valuation multiples stay steady, this should support growth in […]

Read More
Nvidia Investment

NVIDIA Q1 Earnings Preview: Analyst Cautions On Macro Uncertainty, China Restrictions – ‘Stay Long The Stock’

Admin Enterteno

All eyes turn to NVIDIA Corporation (NASDAQ:NVDA) and the company’s AI dominance, new products and questions for the China market when the company reports first-quarter financial results Wednesday after market close.Here are the analyst earnings estimates, what experts are saying ahead of the report and key items to watch.Earnings Estimates: Analysts expect Nvidia to report […]

Read More
Genetic Research And Biotech Science Con

Ultragenyx Is Uniquely Positioned In Long Term, Remains On JPMorgan’s Focus List

Admin Enterteno

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s (NASDAQ:RARE) setrusumab program in osteogenesis imperfecta (OI).In a fourth-quarter 2024 press release, the company said patients continue dosing in the Phase 3 Orbit and Cosmic trials, which evaluate setrusumab in pediatric and young adult patients with OI.The randomized, placebo-controlled Phase 3 portion of the Orbit […]

Read More
Business Analyst Checking In Financial S

GE Aerospace Beats Expectations Across The Board: Analyst Sees Upside In 2025 Guidance

Admin Enterteno

Goldman Sachs analyst Noah Poponak expressed views on GE Aerospace‘s (NYSE:GE) fourth-quarter FY24 results.Today, the company reported fourth-quarter adjusted revenue growth of 16% year-over-year to $9.879 billion and GAAP revenue of $10.812 billion. The analyst consensus was $9.604 billion.Adjusted EPS for the quarter was $1.32 (+103% Y/Y), beating the consensus of $1.04.GE Aerospace expects FY25 […]

Read More
weight loss shutter2

What’s Going On With Amgen Stock On Friday?

Admin Enterteno

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program.When evaluating the effects of treatment if all people adhered to treatment, people treated with CagriSema achieved a weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, […]

Read More
Recession Shutterstock

Veteran Wall Street Analyst Counters Recession Fears: ‘We Don’t Expect A Hard Landing Of The Economy’

Admin Enterteno

Veteran Wall Street investor Ed Yardeni challenged fears of a U.S. recession on Monday, opposing the prevailing market sentiment that unsettled global equities.“A weak July employment report does not make a recession,” wrote Ed Yardeni, president of Yardeni Research, in a morning note published ahead of the stronger-than-expected ISM Services PMI report. Yardeni argues that […]

Read More